Wednesday, November 24, 2021 5:02:36 PM
You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest
Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch
Settlement Date Short Interest Percent Change
Average Daily Share Volume Days to Cover
11/15/2021 177,107 2124.40 808,889 1.00
10/29/2021 7,962 (83.75) 1,857,416 1.00
10/15/2021 49,012 233.69 352,134 1.00
09/30/2021 14,688 (25.95) 119,242 1.00
09/15/2021 19,834 26.07 16,674 1.19
08/31/2021 15,733 (11.53) 18,667 1.00
08/13/2021 17,784 (52.59) 26,087 1.00
07/30/2021 37,510 (51.73) 21,437 1.75
07/15/2021 77,706 904.34 59,460 1.31
06/30/2021 7,737 (32.19) 29,894 1.00
06/15/2021 11,409 (64.02) 8,295 1.38
05/28/2021 31,708 270.85 7,999 3.96
05/14/2021 8,550 (16.24) 27,827 1.00
04/30/2021 10,208 11.62 89,060 1.00
04/15/2021 9,145 495.77 6,454 1.42
03/31/2021 1,535 148.78 65,155 1.00
03/15/2021 617 (99.39) 52,716 1.00
02/26/2021 101,294 12853.20 100,564 1.01
02/12/2021 782 22,705 1.00
Recent SABS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:00:06 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/12/2024 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:30:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 09:00:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 12:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:30:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:30:03 PM
- SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates • GlobeNewswire Inc. • 05/20/2024 09:45:00 PM
- SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors • GlobeNewswire Inc. • 05/06/2024 11:15:00 AM
- SAB Biotherapeutics Provides SAB-142 Trial Update • GlobeNewswire Inc. • 04/16/2024 11:15:00 AM
- SAB Biotherapeutics to Present at INNODIA Annual Meeting • GlobeNewswire Inc. • 04/08/2024 11:15:00 AM
- SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 11:15:00 AM
- SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/29/2024 11:15:00 AM
- SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment • GlobeNewswire Inc. • 03/25/2024 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:55:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:45:19 PM
- SAB Biotherapeutics to Present at the BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/23/2024 01:00:00 PM
- SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 12:53:44 PM
- SAB Biotherapeutics Announces Executive Leadership Change • GlobeNewswire Inc. • 02/02/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 09:15:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/26/2024 09:00:14 PM
Vocodia Enters Medical Alert Industry with Innovative Emergency Response Pendant • VHAI • Oct 25, 2024 8:00 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 • HYDI • Oct 24, 2024 11:18 AM
VAYK Asserts Goal of Q4 Operationally Profitable and Projects Major 2025 Launch • VAYK • Oct 24, 2024 10:40 AM
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push • CBDL • Oct 24, 2024 7:07 AM
ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition • AVXL • Oct 23, 2024 8:03 AM
Forte Minerals to Acquire the Miscanthus Epithermal Gold and Porphyry Copper Prospects in Central Perú with Environmental Drilling Permit (DIA) • CUAU • Oct 23, 2024 7:38 AM